Advertisement

AIDS and Behavior

, Volume 22, Issue 3, pp 752–764 | Cite as

Predictors of Adult Retention in HIV Care: A Systematic Review

  • Shiraze M. Bulsara
  • Milton L. Wainberg
  • Toby R. O. Newton-John
Substantive Review

Abstract

A systematic literature review was conducted to identify predictors of poor adult retention in HIV medical care in developed and developing countries. An electronic search was conducted with MEDLINE (OVID), PubMED, EBSCO, SCOPUS, and Cochrane databases, as well as manual searches. Original, quantitative, adult studies in English, published between 1995 and 2015 were included. Only those with a focus on predictors of retention in care were reported on. Of the 345 articles identified, thirty were included following an independent assessment by two raters. In developed countries, the most frequently cited predictors of poor retention were active substance use and demographic factors. In developing countries, physical health factors were most frequently associated with poor retention in care. The results from this review suggests primary concerns for poor retention include substance use and physical health factors. Other psychosocial factors, such as psychiatric illness and social/welfare factors, were also found to be relevant.

Keywords

Retention HIV Predictors Adult Developing countries Developed countries 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. 1.
    World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2016. http://apps.who.int/iris/bitstream/10665/208825/1/9789241549684_eng.pdf?ua=1. Accessed 4 Aug 2016.
  2. 2.
    Centers for Disease Control and Prevention. Vital signs: HIV prevention through care and treatment—United States. CDC. 2011;60(47):1618–1623. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6047a4.htm. Accessed 12 Mar 2016.
  3. 3.
    The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2015. Sydney: The Kirby Institute, UNSW Australia.Google Scholar
  4. 4.
    National Institutes of Health. Starting antiretroviral treatment early improves outcomes for HIV-infected individuals. https://www.nih.gov/news-events/news-releases/starting-antiretroviral-treatment-early-improves-outcomes-hiv-infected-individuals. Accessed 30 May 2016.
  5. 5.
    Charania MR, Marshall KJ, Lyles CM, Crepaz N, Kay LS, Koenig LJ, et al. Identification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of US-based studies, 1996–2011. AIDS Behav. 2014;18(4):646–60.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Young B. The importance of retention in HIV care. Medscape. 2014. http://www.medscape.com/viewarticle/831324. Accessed 28 Apr 2015.
  7. 7.
    Tedaldi EM, Richardson JT, Debes R, Young B, Chmiel JS, Durham MD, et al. Retention in care within 1 year of initial HIV care visit in a multisite US cohort: who’s in and who’s out?. J Int Assoc Provid AIDS Care. 2014;13:232–41.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    European AIDS Clinical Society. EACS European Guidelines for treatment of HIV infected adults in Europe. http://www.eacsociety.org/Guidelines.aspx. Accessed 28 Apr 2015.
  9. 9.
    Moher D, Shamseer L, Clarke D, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. BMJ. 2015;349:g7647.CrossRefGoogle Scholar
  10. 10.
    Tobias CR, Cunningham W, Cabral HD, Cunningham CO, Eldred L, Naar-King S, et al. Living with HIV but without medical care: barriers to engagement. AIDS Patient Care STDs. 2007;21:426–34.CrossRefPubMedGoogle Scholar
  11. 11.
    Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74.CrossRefPubMedGoogle Scholar
  12. 12.
    Nosyk B, Lourenço L, Min JE, Shopin D, Lima VD, Montaner JS, et al. Characterizing retention in HAART as a recurrent event process: insights into ‘cascade churn’. AIDS. 2015;29(13):1681–9.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    The United Nations. World economic situation and prospects. http://www.un.org/en/development/desa/policy/wesp/wesp_current/2014wesp_country_classification.pdf. Accessed 7 Dec 2015.
  14. 14.
    Althoff AL, Zelenev A, Meyer JP, Fu J, Brown SE, Vagenas P, et al. Correlates of retention in HIV care after release from jail: results from a multi-site study. AIDS Behav. 2013;17(Suppl 2):S156–70.CrossRefPubMedGoogle Scholar
  15. 15.
    Giordano TP, Hartman C, Gifford AL, Backus LI, Morgan RO. Predictors of retention in HIV care among a national cohort of US veterans. HIV Clin Trials. 2009;10(5):299–305.CrossRefPubMedGoogle Scholar
  16. 16.
    Lourenço L, Colley G, Nosyk B, Shopin D, Montaner JSG, Lima VD. High levels of heterogeneity in the HIV cascade of care across different population subgroups in British Columbia, Canada. PLoS ONE. 2014;9:e115277.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Rebeiro P, Althoff KN, Buchacz K, Gill J, Horberg M, Krentz H, et al. Retention among North American HIV-infected persons in clinical care, 2000–2008. JAIDS. 2013;62:356–62.PubMedPubMedCentralGoogle Scholar
  18. 18.
    McMahon JH, Moore R, Eu B, Tee B-K, Chen M, El-Hayek C, et al. Clinic network collaboration and patient tracing to maximize retention in HIV care. PLoS ONE. 2015;10:e0127726.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Blank AE, Fletcher J, Verdecias N, Garcia I, Blackstock O, Cunningham C. Factors associated with retention and viral suppression among a cohort of HIV+ women of color. AIDS Patient Care STDS. 2015;29(Suppl 1):S27–35.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Horberg MA, Hurley LB, Klein DB, Towner WJ, Kadlecik P, Antoniskis D, et al. The HIV care cascade measured over time and by age, sex, and race in a large national integrated care system. AIDS Patient Care STDs. 2015;29(11):582–90.CrossRefPubMedGoogle Scholar
  21. 21.
    Richey LE, Halperin J, Pathmanathan I, Van Sickels N, Seal PS. From diagnosis to engagement in HIV care: assessment and predictors of linkage and retention in care among patients diagnosed by emergency department based testing in an urban public hospital. AIDS Patient Care STDs. 2014;28(6):277–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Adams JW, Brady KA, Michael YL, Yehia BR, Momplaisir FM. Postpartum engagement in HIV care: an important predictor of long term retention in care and viral suppression. Clin Infect Dis. 2015;61(12):1880–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Dombrowski JC, Simoni JM, Katz DA, Golden MR. Barriers to HIV care and treatment among participants in a public health HIV care relinkage program. AIDS Patient Care STDs. 2015;29:279–87.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Schafer KR, Brant J, Gupta S, Thorpe J, Winstead-Derlega C, Pinkerton R, et al. Intimate partner violence: a predictor of worse HIV outcomes and engagement in care. AIDS Patient Care STDs. 2012;26(6):356–65.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Waldrop-Valverde D, Guo Y, Ownby RL, Rodriguez A, Jones DL. Risk and protective factors for retention in HIV care. AIDS Behav. 2014;18(8):1483–91.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Kelly JD, Hartman C, Graham J, Kallen MA, Giordano TP. Social support as a predictor of early diagnosis, linkage, retention, and adherence to HIV care: results from the steps study. J Assoc Nurses AIDS Care. 2014;25(5):405–13.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Boyles TH, Wilkinson LS, Leisegang R, Maartens G. Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme. PLoS ONE. 2011;6(5):e19201.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Charurat M, Oyegunle M, Benjamin R, Habib A, Eze E, Ele P, et al. Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors. PLoS ONE. 2010;5(5):e10584.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Janssen S, Wieten RW, Stolp S, Cremers AL, Rossatanga EG, Klipstein-Grobusch K, Belard S, Grobusch MP. Factors associated with retention to care in an HIV clinic in Gabon, Central Africa. PLoS ONE. 2015;10(10):e0140746.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Koole O, Tsui S, Wabwire-Mangen F, Kwesigabo G, Menten J, Mulenga M, et al. Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia. Trop Med Int Health. 2014;19(12):1397–410.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Mekuria LA, Prins JM, Yalew AW, Sprangers MAG, Nieuwkerk PT. Retention in HIV care and predictors of attrition from care among HIV-infected adults receiving combination anti-retroviral therapy in Addis Ababa. PLoS ONE. 2015;10(6):e0130649.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Mutasa-Apollo T, Shiraishi RW, Takarinda KC, Dzangare J, Mugurungi O, Murungu J, et al. Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe’s National Antiretroviral Therapy Programme, 2007–2010. PLoS ONE. 2014;9(1):e86305.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Thida A, Tun STT, Zaw SKK, Lover AA, Cavailler P, Chunn J, et al. Retention and risk factors for attrition in a large public health ART program in Myanmar: a retrospective cohort analysis. PLoS ONE. 2014;9(9):e108615.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Ugoji C, Okere N, Dakum P, Ake-Uzoigwe R, Igboelina D, Ndembi N, Ekong E, Charurat M, Blattner WA. Correlates of patient retention in HIV care and treatment programs in Nigeria. Curr HIV Res. 2015;13(4):300–7.CrossRefPubMedGoogle Scholar
  35. 35.
    Vella V, Govender T, Dlamini S, Taylor M, Moodley I, David V, et al. Retrospective study on the critical factors for retaining patients on antiretroviral therapy in KwaZulu-Natal, South Africa. JAIDS. 2010;55(1):109–16.PubMedGoogle Scholar
  36. 36.
    Yang GL, Yan J, Liu Y, Huang ZL, Long S. Retention in care and factors affecting it among people living with HIV/AIDS in Changsha city, China. Asia-Pacific J Public Health. 2015;27(2 suppl):86S–92S.CrossRefGoogle Scholar
  37. 37.
    Allam RR, Murhekar MV, Bhatnagar T, Uthappa CK, Chava N, Rewari BB, et al. Survival probability and predictors of mortality and retention in care among patients enrolled for first-line antiretroviral therapy, Andhra Pradesh, India, 2008–2011. Trans R Soc Trop Med Hyg. 2014;108:198–205.CrossRefPubMedGoogle Scholar
  38. 38.
    Palombi L, Marazzi MC, Guidotti G, Germano P, Buonomo E, Scarcella P, et al. Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral-treated patients in sub-Saharan African Sites with comprehensive monitoring availability. Clin Infect Dis. 2009;48(1):115–22.CrossRefPubMedGoogle Scholar
  39. 39.
    Vuylsteke B, Semdé G, Auld AF, Sabatier J, Kouakou J, Ettiègne-Traoré V, et al. Retention and risk factors for loss to follow-up of female and male sex workers on antiretroviral treatment in Ivory Coast: a retrospective cohort analysis. JAIDS. 2015;68:S99–106.PubMedGoogle Scholar
  40. 40.
    Krumme AA, Kaigamba F, Binagwaho A, Murray MB, Rich ML, Franke MF. Depression, adherence and attrition from care in HIV-infected adults receiving antiretroviral therapy. J Epidemiol Community Health. 2014;69:284–9.CrossRefPubMedGoogle Scholar
  41. 41.
    National Institute on Drug Abuse. Drugs, brain and behavior: the science of addiction. https://www.drugabuse.gov/publications/drugs-brains-behavior-science-addiction/drugs-brain. Accessed 20 Mar 2016.
  42. 42.
    Hull P, Mao L, Kao S-C, Edwards B, Prestage G, Zablotska I, et al. Gay Community Periodic Survey: Sydney 2013. Sydney: National Centre in HIV Social Research, University of New South Wales.Google Scholar
  43. 43.
    Hatzenbuehler ML. How does sexual minority stigma “get under the skin”? A psychological mediation framework. Psychol Bull. 2009;135(5):707.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Springer SA, Dushaj A, Azar MM. The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review. AIDS Behav. 2012;16(8):2119–43.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Sayles JN, Wong MD, Kinsler JJ, Martins D, Cunningham WE. The association of stigma with self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS. J Gen Intern Med. 2009;24(10):1101–8.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Johnson MO, Neilands TB, Dilworth SE, Morin SF, Remien RH, Chesney MA. The role of self-efficacy in HIV treatment adherence: validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES). J Behav Med. 2007;30(5):359–70.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Clinical Psychology, Graduate School of HealthUniversity of Technology Sydney (UTS)Ultimo, SydneyAustralia
  2. 2.The Albion CentreSurry Hills, SydneyAustralia
  3. 3.Department of PsychiatryColumbia UniversityNew YorkUSA

Personalised recommendations